Jump to navigation
The National Centre for Clinical Research on Emerging Drugs (NCCRED) has engaged NCETA to develop a Workforce Development (WFD) Strategy.
This study will investigate the first online alcohol and substance use prevention program targeted at both students and their parents.
AOD use has a negative impact on workplaces and may result in accidents, injuries, reduced productivity, abstenteesim, poor work relationships and
NDRI researchers will be collaborating with others to update the social and economic costs of smoking in Australia.
Tapentadol is a centrally acting opioid analgesic with dual mechanisms of action, specifically µ-opioid receptor agonist and noradrenaline reuptake
The majority of smokers want to quit smoking but stopping is hard.
This study will evaluate an evidence based approach to the design of a new treatment service for users of methamphetamine.
This project will investigate the feasibility of delivering routine alcohol screening and brief intervention in hospital emergency departments and emergency short stay units.
NCETA is working with NADA to develop a core capability/competency framework for the AOD community-based sector in New South Wales.
The aim of this survey is to develop an understanding of the mental health, sexual health and reproductive health of adolescents in contact with the criminal justice system in Queensland and Western Australia.
NDRI researcher David Moore has been awarded an ARC grant to lead a novel study aimed at increasing the capacity of alcohol research and policy to address gender issues.
The national centres are supported by funding from the Australian Government under the Drug and Alcohol Program
Page last updated: Friday 7 December 2018